2breathe Technologies Ltd. and its founders are pioneers in the development of the digital therapeutic devices field, first in hypertension and now in sleeplessness. The original product, RESPeRATE® (www.resperate.com), is the world’s first FDA-cleared, non-drug hypertension treatment device now used by hundreds of thousands of patients is featured in the American Heart Association statement on non-pharmacological treatments. The new product, 2breathe™, adopts RESPeRATE guided-breathing technology for individuals who have difficulties falling asleep. 2breathe is not a medical device and is not intended to diagnose or treat medical conditions.
Company Details
- Employees
- 8
- Address
- St, Tel Aviv,israel
- Industry
- Medical Device
- Website
- http://www.resperate.com
- HQ
- Tel Aviv
2breathe Technologies Ltd. Questions
2Breathe Technologies Ltd.'s website is http://www.resperate.com
2Breathe Technologies Ltd.'s LinkedIn profile is https://www.linkedin.com/company/2breathetechnologies
2Breathe Technologies Ltd. has
8 employees.
View email and phone details for 8
employees at 2Breathe Technologies Ltd..
2Breathe Technologies Ltd.'s industry is
Medical Device
2Breathe Technologies Ltd.'s top competitors are
Somnopatch,
Cannatechglobal,
Bt Beamedical Technologies / Beamed,
Cann10 - Medical Cannabis,
B.i.sync Ltd,
Ati- Advanced Medical Technologies Ltd,
Intellibreathe,
Cannegev,
Mirrori,
Bookmaker Ratings.
2Breathe Technologies Ltd.'s categories are Medical Device
